COMP360 psilocybin therapy shows potential in open-label stu

COMP360 psilocybin therapy shows potential in open-label study in type II bipolar disorder presented at ACNP

COMP360 psilocybin therapy shows potential in open-label study in type II bipolar disorder presented at ACNP
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United Kingdom , United States , Arizona , California , Phoenix , La Jolla , London , City Of , Friston , East Sussex , America , David Feifel , Sheppard Pratt Baltimore , Stephen Schultz , Amy Lawrence , Sheppard Pratt , Scott Aaronson , Psychiatric Sciences , Institute For Advanced Diagnostics , Linkedin , Drug Administration , Young , Kadima Neuropsychiatry Institute , Nasdaq , Other Common Mental Disorders Global Health , National Institute Of Mental Health , Exchange Commission , Meeting Of The American College Neuropsychopharmacology , Annual Meeting , American College , Depression Rating Scale , Chief Science Officer , Advanced Diagnostics , Principal Investigator , New England Journal , Guy Goodwin , Chief Medical Officer , Emotional Breakthrough Inventory , Five Dimensional Altered States , North America , Breakthrough Therapy , Innovative Licensing , Access Pathway , Securities Act , Private Securities Litigation Reform Act , Open Label Study , Proprietary Synthetic Psilocybin , Global Crisis , Affective Disorders , General Psychiatry , Bipolar Disorder , Indian Journal , Psychological Medicine , Current Psychiatry Reports , Anarchic Brain , Unified Model , Brain Action , Pharmacological Reviews ,